摘要
目的探讨高龄、高危前列腺增生患者经尿道等离子电切治疗的安全性和有效性。方法分析我院2006年7月~2014年7月185例高龄、高危前列腺增生患者应用经尿道等离子双极汽化电切术的临床资料。结果手术时间(62.0±21.3)min,切除前列腺体积(38.0±15.7)m L,术中出血量(78.0±32.5)m L,术后随诊6~18个月,全部病例下尿路症状(LUTS)改善良好,国际前列腺症状评分(IPSS)由术前平均(25.7±4.5)下降至(6.4±1.7)分,最大尿流率由术前(6.5±2.3)m L/s上升至(18.8±3.5)m L/s,残余尿由术前(87.9±7.6)m L下降至(16.6±7.4)m L。结论对高龄高危前列腺增生患者应用经尿道等离子汽化电切术安全有效,采用个体化治疗方案,加强术前监测,调整用药,做好术中、术后每一个细节处理,是保证手术效果及围手术期安全的关键。
Objective To explore the safety and efficacy about the transurethral plasma kinetic resection of the prostate(TUPKRP) in the treatment of elderly high-risk patient with benign prostatic hyperplasia(BPH). Methods Analysis of the clinical data of 185 cases of elderly high-risk patients with BPH from July 2006 to July 2014, application of transurethral plasma kinetic resection of the prostate(TUPKRP). Results The operation time was(62.0±21.3) minutes,resection of the prostate volume(38.0±15.7)m L, the average amount of bleeding was(78.0±32.5) m L. After 6-18 months follow up, all patients with lower urinary tract symptoms(LUTS) improved well, the IPSS score went down from preoperative(25.7±4.5) to(6.4±1.7), the Qmax increased from preoperative(6.5±2.3)m L/s up to(18.8±3.5)m L/s, residual urine(PVR) down from preoperative(87.9±7.6)m L to(16.6±7.4)m L. Conclusion TUPKRP is safe and effective for the treatment of elderly high-risk patient with BPH, the individual treatment,intensive monitoring and adjustment before operation, and skilled manipulation were the keys to the success.
出处
《中国现代医生》
2016年第5期44-47,共4页
China Modern Doctor
关键词
前列腺增生
下尿路症状
高龄高危
经尿道等离子前列腺电切术
Benign prostatic hyperplasia
Lower urinary tract symptoms
Elderly high-risk
Transurethral plasma kinetic resection of the prostate